Cervical Cancer Trial

GOG 0263

Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and  Pelvic Lymphadenectomy

Purpose

This trial studies radiation therapy with chemotherapy to see how well it works compared to radiation therapy alone in treating patients with stage I or stage II cervical cancer who previously underwent surgery.

Eligibility:

This study is looking for patients who have cervical cancer stage I-IIA treated with radical hysterectomy.

Learn more about this study.

RTOG 0724

Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy

Purpose

This trial is studying chemotherapy and pelvic radiation therapy to see how well they work when given with or without additional chemotherapy in treating patients with high-risk early-stage cervical cancer after radical hysterectomy.

Eligibility:

This study is looking for patients with Stage IA2, IB or IIA cervical cancer who have had a radical hysterectomy.

Learn more about this study.

For more information about cancer-related clinical trials, call (260) 425-6800 and ask to speak to a clinical research coordinator. You may also e-mail oncology.research@parkview.com.

Parkview Cancer Institute
11050 Parkview Circle
Fort Wayne, Indiana 46845

Search By Cancer Type

 

Need assistance?

Contact us